Brain Cancer Trial, Recruiting NCT07465796 Sponsor: Coherence Neuro Australia Pty Limited Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT07465796
Recruiting Not Applicable 🇦🇺 Australian site

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been newly diagnosed with a type of brain tumour called a supratentorial glioma that needs to be surgically removed
  • People whose tumour reaches or is close to the surface of the brain
  • Adults between 18 and 75 years of age
  • People whose surgery is planned to be an open brain surgery performed while they are fully asleep under general anaesthesia (using a specific method called Total Intravenous Anaesthesia)
  • People who are able to give their own written agreement to take part in the trial
  • People with a general health and activity level that falls within a certain range, meaning they are able to carry out basic daily activities, even if some limitations are present (confirm with trial site)

Who may not be able to join:

  • People who have previously had brain surgery in the same area of the brain
  • People whose surgery is planned to be performed while they are awake
  • People who have a history of seizures or epileptic episodes before their brain surgery
  • People who have a history of problems with blood clotting or bleeding disorders
  • People who are pregnant at the time of the planned surgery

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +61 393 482 712

Australian sites

The Royal Melbourne Hospital, Department of Neurosurgery 4 East, Melbourne, Victoria
+61 393 482 712

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Coherence Neuro Australia Pty Limited
Registry
ClinicalTrials.gov
Start date
22 May 2026
Est. completion
1 September 2026

Where this trial is recruiting

🇦🇺 Australia

1 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Incidence of all device/procedure-related adverse events (safety and tolerability) relevant to the intended use of the study device

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov